iBio (IBIO) EBITDA Margin Growth (5y) (2016 - 2025)
iBio (IBIO) EBITDA Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -426,222.00 |
| Jun 30, 2025 | -233,748.00 |
| Dec 31, 2024 | -120,472.00 |
| Jun 30, 2024 | -143,819.00 |
| Sep 30, 2023 | -142,822.00 |
| Mar 31, 2022 | 1.03 Mn |
| Sep 30, 2021 | -388,394.00 |
| Jun 30, 2021 | -92,095.00 |
| Mar 31, 2021 | -13,101.00 |
| Dec 31, 2020 | 61,188.00 |
| Sep 30, 2020 | -55,566.00 |
| Jun 30, 2020 | 33,848.00 |
| Mar 31, 2020 | -374,967.00 |
| Dec 31, 2019 | -55,083.00 |
| Sep 30, 2019 | -339,655.00 |
| Jun 30, 2019 | 5,165.00 |
| Jun 30, 2018 | -412,524.00 |
| Sep 30, 2017 | -229,082.00 |
| Jun 30, 2017 | -201,374.00 |
| Mar 31, 2017 | -1.01 Mn |